All News #Library
Biotech
PharmAbcine Announces Safety Approval For PMC-403 Trial
14 Oct 2024 //
PR NEWSWIRE
PharmAbcine Publishes Study in Advances Demonstrating the Potential of PMC-403
22 Nov 2023 //
PR NEWSWIRE
PharmAbcine Receives Approval to Advance to Dose Level 2 of Trial of PMC-403
09 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support